共 105 条
[1]
Miettinen M(2011)Histopathology of gastrointestinal stromal tumor.[J] Journal of Surgical Oncology 104 865-873
[2]
Lasota J(2012)Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.[J] Lancet Oncology 13 265-274
[3]
Joensuu H(1998)Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors[J] Science 279 577-1104
[4]
Vehtari A(2001)Tyrosine kinase inhibitor imatinib (STIS71) as an anticancer agent for solid tumours[J] Annals of Medicine 33 5-72
[5]
Riihimäki J(2009)Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial[J] Lancet 373 1097-180
[6]
Hirota S(2012)One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: A randomized trial[J] Jama 307 1265-1605
[7]
Isozaki K(2000)Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases.[J] Surgery Today 30 177-1554
[8]
Moriyama Y(2010)NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors[J] Journal of the National Comprehensive Cancer Network Jnccn 8 S1-2948
[9]
Joensuu H(2007)NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)–update of the NCCN clinical practice guidelines[J] J Natl Compr Canc Netw 2 S1-873
[10]
Dimitrijevic S(2010)Impact of the introduction of laparoscopic wedge resection as a surgical option for suspected small/medium-sized gastrointestinal stromal tumors of the stomach on perioperative and oncologic outcomes.[J] World Journal of Surgery 34 1847-55